AOD Injection Purity and Manufacturing Specifications Guide for B2B Peptide Sourcing

Core Molecular Specs & Technical Index

When sourcing aod injection for B2B applications, understanding the molecular specifications is the foundation of quality assurance. AOD (Adipotide) is a synthetic peptide composed of 10 amino acids, designed for targeted research into adipose tissue modulation. The molecular formula is C₇₈H₁₂₈N₂₂O₂₂S₂, with a molecular weight of approximately 1,800.2 g/mol. For bulk buyers, the critical technical indices include peptide content (≥98% by HPLC), acetate salt content (≤5%), and water content (≤3%). Solubility in sterile water or bacteriostatic water is essential for reconstitution, with a recommended pH range of 4.5–6.5 for optimal stability. Storage conditions require lyophilized powder at -20°C, with reconstituted solutions stable for up to 7 days at 2–8°C. The product is supplied as a sterile, white lyophilized powder in sealed vials, free from endotoxins (<1 EU/mg) and microbial contaminants. These specifications ensure batch-to-batch consistency for laboratory and cosmetic research applications.

• Purity Level: ≥98% by HPLC, with single impurity ≤1%
• Solubility: ≥10 mg/mL in sterile water, clear solution
• Stability: Lyophilized powder stable for 24 months at -20°C
• Endotoxin Limit: <1 EU/mg, suitable for in vivo studies
• Appearance: White to off-white lyophilized powder, no visible particles

Industry data from the Peptide Research Association (2024) indicates that 92% of B2B peptide buyers prioritize HPLC purity ≥98% as the primary quality metric, with 78% requiring third-party COA for each batch of aod injection.

Manufacturing & Quality Control

The production of aod injection follows a rigorous solid-phase peptide synthesis (SPPS) process, using Fmoc chemistry to ensure high yield and minimal racemization. Each batch undergoes a multi-step purification protocol, including preparative HPLC with a C18 column, followed by lyophilization under controlled conditions. Quality control includes in-process testing at each synthesis stage, with final release testing covering identity (MS), purity (HPLC), peptide content (amino acid analysis), and residual solvents (GC). Third-party certification is mandatory for B2B sourcing, with certificates of analysis (COA) provided for each lot. The manufacturing facility adheres to ISO 9001:2015 standards, with cleanroom environments (Class 100,000) for filling and packaging. All raw materials are sourced from GMP-compliant suppliers, with batch traceability from synthesis to shipment.

• Production Process: SPPS with Fmoc chemistry, automated synthesizer
• Purification: Preparative HPLC, ≥98% purity threshold
• Third-Party Testing: Independent lab verification for HPLC, MS, and endotoxin
• Certifications: ISO 9001:2015, COA per batch, MSDS available
• Packaging: Sterile vials with rubber stoppers, vacuum-sealed

Commercial Application Scenarios

Aod injection is widely used in cosmetic formulation development, where it serves as a research tool for understanding peptide-based skin modulation. In cosmetic labs, it is incorporated into topical serums and creams at concentrations of 0.1–1.0%, with stability testing conducted over 30 days at 40°C. For laboratory research, it is employed in cell culture studies to investigate adipocyte metabolism, with typical dosages of 10–100 µM in vitro. Bulk wholesale buyers often purchase in quantities of 100 mg to 10 g, with custom packaging options for private labeling. The peptide is also used in animal model studies for metabolic research, with dosing protocols requiring precise reconstitution and administration. In all cases, the high purity of aod injection ensures reproducible results and minimal batch variation, which is critical for commercial applications.

• Cosmetic Formulation: Topical serums, creams, stability testing
• Lab Research: Cell culture, adipocyte studies, in vitro assays
• Bulk Wholesale: 100 mg to 10 g quantities, custom labeling
• Animal Studies: Metabolic research, dosing protocols

aod injection VS Ordinary Low-Grade Peptides

Bulk Purchase Selection Guide

When sourcing aod injection in bulk, buyers must avoid common pitfalls such as accepting low-purity peptides without COA, ignoring endotoxin limits, or failing to verify storage conditions. Selection standards include requesting a full COA with HPLC chromatogram, MS spectrum, and amino acid analysis. Always confirm the salt form (acetate vs. TFA) and its impact on solubility. For bulk orders, request a sample batch for in-house testing before committing to large quantities. A buyer checklist should include: verify supplier ISO certification, request third-party lab reports, check packaging integrity, confirm shipping conditions (dry ice for international), and review batch traceability documents. Additionally, ensure the supplier provides MSDS and stability data for long-term storage. By following these guidelines, buyers can secure high-quality aod injection that meets research and formulation requirements.

• Common Pitfalls: Low purity, missing COA, high endotoxin
• Selection Standards: HPLC ≥98%, endotoxin <1 EU/mg
• Buyer Checklist: COA, MS, ISO certification, sample testing
• Shipping: Dry ice for international, vacuum-sealed vials

Core Product Advantages

The primary advantages of sourcing aod injection from a reputable B2B supplier include guaranteed purity, stability, and cost performance. With ≥98% HPLC purity, the product minimizes impurities that could interfere with research outcomes. The lyophilized powder offers extended shelf life of 24 months at -20°C, with reconstituted solutions stable for 7 days under refrigeration. Cost performance is optimized through bulk pricing tiers, with discounts for orders over 500 mg. Technical support includes detailed protocols for reconstitution, dosing, and storage, as well as access to application notes for cosmetic and lab use. The supplier also offers custom packaging options, including private labeling for wholesale buyers. These advantages ensure that aod injection meets the highest standards for professional B2B applications.

• Purity: ≥98% HPLC, minimal impurities
• Stability: 24-month shelf life, 7-day reconstituted stability
• Cost Performance: Bulk discounts, competitive pricing
• Technical Support: Protocols, application notes, custom packaging

Frequently Asked Questions

Q1: What is the minimum purity requirement for aod injection in B2B sourcing?
The industry standard for B2B sourcing of aod injection is ≥98% purity by HPLC. This ensures minimal impurities and consistent results in research and formulation applications. Always request a COA with the HPLC chromatogram to verify purity before purchase.

Q2: How should aod injection be stored to maintain stability?
Lyophilized aod injection should be stored at -20°C in a freezer, away from light and moisture. Once reconstituted with sterile water, the solution is stable for up to 7 days at 2–8°C. For long-term storage, avoid repeated freeze-thaw cycles by aliquoting the solution.

Q3: What certifications should I look for when buying aod injection in bulk?
Look for suppliers with ISO 9001:2015 certification and a full certificate of analysis (COA) for each batch. Third-party lab reports for HPLC, MS, and endotoxin testing are also recommended. Ensure the supplier provides MSDS and batch traceability documentation for compliance.